Photo courtesy of the city of New Haven

With a May 8 sale, New Haven-based Biohaven Pharmaceuticals now controls three properties on Church Street in the city’s downtown: its current home plus neighboring parcels on either side.

Biohaven bought 209 Church St., a former bank branch, for $2.35 million according to a warranty deed filed with the city clerk’s office. The New Haven Independent first reported the sale.

The seller was local commercial landlord Olympia Properties. No mortgage appears to have been filed as part of the sale.

It bought its current U.S. headquarters at 215 Church St. – also a former bank branch – in 2018, and neighboring 221 Church St. in 2022. Its latest acquisition is currently vacant. It’s not clear what the company’s plans are for the building or for the total assemblage.

Biohaven is a clinical-stage biotech with over 200 employees that recently raised $247.8 million via a public stock offering in April. In addition to that haul, the company reported a cash balance of $287.6 million at the end of the first quarter and, in that earnings report, claimed it “is well positioned to achieve significant, value-creating milestones in 2024” across several of its drugs currently under development.